SA
Sign upLog In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Net Change in Cash

-$4.89M

TTM · Period ending: · USD

LCTX logo

LCTX Net Change in Cash

Latest reported-$4.89M
LCTX TTM Net Change in Cash (-$1.50M → -$4.89M)
High-resolution chart · PNG

LCTX net change in cash history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Net Change in Cash — Trailing twelve months (TTM) (USD)
Period endingNet Change in Cash (USD)
-2,233,903
-3,365,865
-3,974,468
-4,579,376
-4,773,124
-4,912,623
2,792,806
3,300,000
2,900,000
-3,100,000
-10,300,000
-9,900,000
-8,400,000
4,500,000
5,400,000
5,400,000
4,300,000
1,400,000
1,000,000
2,600,000
2,700,000
-400,000
-1,200,000
-900,000
-700,000
-2,600,000
-1,500,000
-3,300,000
-3,400,000
-1,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.